RPRX – royalty pharma plc - class a ordinary shares (US:NASDAQ)

News

Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Royalty Pharma targets 3%–8% royalty receipts growth in 2026 while advancing $4.7B in transactions [Seeking Alpha]
Royalty Pharma Q4 Earnings Call Highlights [Yahoo! Finance]
Royalty Pharma (NASDAQ:RPRX) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings [Yahoo! Finance]
Royalty Pharma: Q4 Earnings Snapshot [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com